Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Abdominal aortic aneurysm (AAA), a degenerative vascular pathology characterized by permanent dilation of the aorta, is considered a chronic inflammatory disease involving innate/adaptive immunity. However, the functional role of antibody-dependent immune response against antigens present in the damaged vessel remains unresolved. We hypothesized that engagement of immunoglobulin G (IgG) Fc receptors (FcγR) by immune complexes (IC) in the aortic wall contributes to AAA development. We therefore evaluated FcγR expression in AAA lesions and analysed whether inhibition of FcγR signaling molecules (γ-chain and Syk kinase) influences AAA formation in mice.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>FcγR gene/protein expression was assessed in human and mouse AAA tissues. Experimental AAA was induced by aortic elastase perfusion in wild-type (WT) mice and γ-chain knockout (γKO) mice (devoid of activating FcγR) in combination with macrophage adoptive transfer or Syk inhibitor treatment. To verify the mechanisms of FcγR in vitro, vascular smooth muscle cells (VSMC) and macrophages were stimulated with IgG IC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>FcγR overexpression was detected in adventitia and media layers of human and mouse AAA. Elastase-perfused γKO mice exhibited a decrease in AAA incidence, aortic dilation, elastin degradation, and VSMC loss. This was associated with (1) reduced infiltrating leukocytes and immune deposits in AAA lesions, (2) inflammatory genes and metalloproteinases downregulation, (3) redox balance restoration, and (4) converse phenotype of anti-inflammatory macrophage M2 and contractile VSMC. Adoptive transfer of FcγR-expressing macrophages aggravated aneurysm in γKO mice. In vitro, FcγR deficiency attenuated inflammatory gene expression, oxidative stress, and phenotypic switch triggered by IC. Additionally, Syk inhibition prevented IC-mediated cell responses, reduced inflammation, and mitigated AAA formation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Our findings provide insight into the role and mechanisms mediating IgG-FcγR-associated inflammation and aortic wall injury in AAA, which might represent therapeutic targets against AAA disease.</p></section>

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

Unraveling the role of galectin-3 in cardiac pathology and physiology

Sex-specific role of galectin-3 in aortic stenosis

Ablation of Galectin-12 Inhibits Atherosclerosis through Enhancement of M2 Macrophage Polarization

Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B

Myocardin related transcription factor and galectin-3 drives lipid accumulation in human blood vessels

Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models

Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk

Signalling Pathways Regulating Galactosaminoglycan Synthesis and Structure in Vascular Smooth Muscle: Implications for Lipoprotein Binding and Atherosclerosis

Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis

The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease

SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice

AGGF1 therapy inhibits thoracic aortic aneurysms by enhancing integrin α7-mediated inhibition of TGF-β1 maturation and ERK1/2 signaling

Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development

Galectin-9: A Suppressor of Atherosclerosis?

Role of Galectin-3 in resident macrophages and effects on atherosclerosis

Galectin-3 in Cardiovascular Diseases

Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity

Galectin-3 as a novel biotarget in cardiovascular alterations associated to development of severe aortic stenosis

Pre-treatment with galectin-1 attenuates lipopolysaccharide-induced myocarditis by regulating the Nrf2 pathway

Galectin-1 Attenuates Hepatic Ischemia Reperfusion Injury in Mice.